Solventum (SOLV) Stock: Buy, Sell, or Hold?
SOLV - Solventum Corporation
$87.45
-0.20 (-0.23%)
âŧ
5d:
-5.4%
30d:
+2.53%
90d:
+10.39%
WAIT
LOW Confidence
Analysis Updated: Sep 11, 2026 12:00 AM ET
Earnings: Nov 05, 2026
Smart Money Accumulation
Options open interest is building while the stock consolidates - a pattern consistent with institutional accumulation. View Scanner →
Signal fired Sep 4, 2026 at $91.69 · last confirmed Sep 8, 2026
Strength: 5.9/10
Get Alerted When SOLV Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: SOLV is fairly priced but lacks strong directional signals. At 2.4% expected growth, valuation appears fair. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: SOLV is fairly priced but lacks strong directional signals. At 2.4% expected growth, valuation appears fair. Wait for clearer setup or better entry on dips.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$92.56
Based on 2.6% avg growth
INTRINSIC VALUE TODAY
$57.47
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 11.3x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: SOLV is currently trading at $87.45, which is considered fair relative to its 30-day fair value range of $85.88 to $91.33. The stock's valuation (Forward PE: 12.1) is in line with its historical norms (11.3). At these levels, the market is pricing in 2.4% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, SOLV is in a strong uptrend. The price is currently testing key support at $86.65. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: SOLV scores 32/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. In the options market, Implied Volatility is low (2th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, SOLV is in a strong uptrend. The price is currently testing key support at $86.65. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: SOLV scores 32/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. In the options market, Implied Volatility is low (2th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$85.88 -
$91.33
Company Quality Score
45/100
(HOLD)
Options IV Signal
2th percentile
(LOW)
Volume Confirmation
HIGH
Confidence Score
56.5%
Protect Your Profits
Holding SOLV? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- NEUTRAL: Price in fair range
- BULLISH: Options cheap (IV 2th percentile)
- BEARISH: Weak technical setup (32/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($93.92)
- NEUTRAL: Market pricing in 2.4% annual earnings growth - fairly valued
- WARNING: Composite score 45/100 in the bottom quintile â this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$85.88 -
$91.33
Current vs Trading Range
FAIR
Expected Move (7 Days)
Âą$3.93
(4.5%)
Support & Resistance Levels
Support Level
$86.65
Resistance Level
$94.16
Current Trend
Strong Uptrend
Technical data as of
Sep 11, 2026
Fundamental Context
Forward P/E (Next Year Est.)
12.11
Wall Street Target
$93.92
(+7.4%)
Revenue Growth (YoY)
2.2%
Earnings Growth (YoY)
3.9%
Profit Margin
17.3%
Valuation Premium vs History
+2.4% premium
PE vs Historical
12.1 vs 11.3
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+2.4%
(market-implied from PE analysis)
1-Year Target
$89.55
(+2%)
2-Year Target
$91.70
(+5%)
3-Year Target
$93.90
(+7%)
3-Yr Target (if PE normalizes)
(PE: 12â11)
PE COMPRESSION
$87.65
(+0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 20.2, Growth: 1.1%)
$150.72
(+72%)
Base:
(SPY PE: 12.1, Growth: 1.1%)
$90.46
(+3%)
Bear:
(PE: 10.3, Growth: 1.1%)
$76.89
(-12%)
đ
Valuation based on Current Earnings
Trailing PE: 11.00 | Current EPS (TTM): $7.97
Bull Case
$87.39
(0%)
Analyst growth -9.4%, PE expands to 12.1
Base Case
$79.44
(-9%)
Market implied -9.4%, PE stable at 11.0
Bear Case
$59.60
(-32%)
Severe decline -20.0%, PE contracts to 9.4
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: September 12, 2026 11:42 PM ET
Data refreshes hourly during market hours. Next update: 12:42 AM
Data refreshes hourly during market hours. Next update: 12:42 AM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SOLV showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Instruments & Supplies Stocks
Top-rated stocks in Medical Instruments & Supplies by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ISRG
Intuitive Surgical Inc |
BUY
33 analysts |
$478 | 53 HOLD |
|
ALC
Alcon AG |
STRONG BUY
27 analysts |
$85 | 35 SELL |
|
WST
West Pharmaceutical ServâĻ |
STRONG BUY
13 analysts |
$405 | 63 BUY |
|
RGEN
Repligen Corporation |
STRONG BUY
19 analysts |
$188 | 45 HOLD |
|
RMD
ResMed Inc |
BUY
19 analysts |
$246 | 41 HOLD |
Advanced SOLV Option Strategies
Professional options setups generated by AI based on today's SOLV price and gamma walls.
